
Browsing restrictions can be lifted for a fee.
-7.22%
Im cannabis corp.
-1.10%
Avg of Sector
-0.49%
S&P500
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2025Q4 | |||||||
| 2025Q3 | |||||||
| 2025Q2 | |||||||
| 2025Q1 |
The most recent financial report for Im cannabis corp. (IMCC) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating IMCC's short-term business performance and financial health. For the latest updates on IMCC's earnings releases, visit this page regularly.
According to the latest financial report, Im cannabis corp. (IMCC) reported an Operating Profit of -7.24M with an Operating Margin of -46.17% this period, representing a decline of 105.97% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
In the latest financial report, Im cannabis corp. (IMCC) announced revenue of 15.68M, with a Year-Over-Year growth rate of 17.62%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
As of the end of the reporting period, Im cannabis corp. (IMCC) had total debt of 16.27M, with a debt ratio of 0.51. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
At the end of the period, Im cannabis corp. (IMCC) held Total Cash and Cash Equivalents of 3.31M, accounting for 0.1 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
In the latest report, Im cannabis corp. (IMCC) did not achieve the “three margins increasing” benchmark, with a gross margin of 0.5%%, operating margin of -46.17%%, and net margin of -47.4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess IMCC's profit trajectory and future growth potential.
According to the past four quarterly reports, Im cannabis corp. (IMCC)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -1.91. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
Im cannabis corp. (IMCC)'s Free Cash Flow (FCF) for the period is 4.22M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 202.11% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
The latest valuation data shows Im cannabis corp. (IMCC) has a Price-To-Earnings (PE) ratio of -0.29 and a Price/Earnings-To-Growth (PEG) ratio of -0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.